Galectin Therapeutics Preclinical Research on Galectin-3 Role in PAH to be Presented at ATS 2016
News, Pulmonary Hypertension
Galectin Therapeutics, Inc., a biopharmaceutical company that develops therapeutic compounds that bind and inhibit galectin proteins with pathological activity, announced recently that its collaborative abstract on galectin-3 and its role ... Read more